Treatment of mice with a PDE-5 inhibitor reduces the ability of MDSC to inhibit CD8+ T cells and leads to delayed tumor growth in mice inoculated with CT26WT colon carcinoma cells (a sign that T cell-mediated immunity might have been restored). The gene discussed is PDE5A; the disease is neoplasm.